Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Y Feng

Showing results (21-30 of 459) with videos related to

Pageof 46
Sort By:
Prostate International|August 23, 2017
Characteristics and national trends of patients receiving treatment of the primary tumor for metastatic prostate cancerSumi Sinha, Vinayak Muralidhar, Felix Y Feng, et al.
Immunotherapy|August 4, 2017
Convergence of immunotherapy, radiotherapy and prostate cancer: challenges and opportunitiesMichael Green, Felix Y Feng, Rohit Mehra, et al.
Physics in Medicine and Biology|December 15, 2020
Effect of microdistribution of alpha and beta-emitters in targeted radionuclide therapies on delivered absorbed dose in a GATE model of bone marrowJonathan Tranel, Felix Y Feng, Sara St James, et al.
BMJ Evidence-Based Medicine|December 28, 2020
Early salvage versus adjuvant therapy for treatment of prostate cancer following prostatectomyMeera Garriga, Felix Y Feng, W Robert Lee, et al.
Molecular Imaging|September 7, 2006
Chloroquine treatment increases detection of 5-fluorouracil-induced apoptosis index in vivoMukesh K Nyati, Felix Y Feng, Vinayak D Kanade, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2014
Molecular pathways: targeting ETS gene fusions in cancerFelix Y Feng, J Chad Brenner, Maha Hussain, et al.
Translational Andrology and Urology|July 28, 2018
Genomic biomarkers in prostate cancerZachary Kornberg, Matthew R Cooperberg, Daniel E Spratt, et al.
Urology|June 26, 2019
Author ReplyLauren Boreta, Adam J Gadzinski, Thomas A Hope, et al.
Surgical Pathology Clinics|November 7, 2022
Molecular Genetics of Prostate Cancer and Role of Genomic TestingDilara Akhoundova, Felix Y Feng, Colin C Pritchard, et al.
Nature Reviews. Cancer|October 13, 2006
Integration of EGFR inhibitors with radiochemotherapyMukesh K Nyati, Meredith A Morgan, Felix Y Feng, et al.
Pageof 46

Showing results (21-30 of 459) with videos related to

Sort By:
Pageof 46
Prostate International|August 23, 2017
Characteristics and national trends of patients receiving treatment of the primary tumor for metastatic prostate cancerSumi Sinha, Vinayak Muralidhar, Felix Y Feng, et al.
Immunotherapy|August 4, 2017
Convergence of immunotherapy, radiotherapy and prostate cancer: challenges and opportunitiesMichael Green, Felix Y Feng, Rohit Mehra, et al.
Physics in Medicine and Biology|December 15, 2020
Effect of microdistribution of alpha and beta-emitters in targeted radionuclide therapies on delivered absorbed dose in a GATE model of bone marrowJonathan Tranel, Felix Y Feng, Sara St James, et al.
BMJ Evidence-Based Medicine|December 28, 2020
Early salvage versus adjuvant therapy for treatment of prostate cancer following prostatectomyMeera Garriga, Felix Y Feng, W Robert Lee, et al.
Molecular Imaging|September 7, 2006
Chloroquine treatment increases detection of 5-fluorouracil-induced apoptosis index in vivoMukesh K Nyati, Felix Y Feng, Vinayak D Kanade, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2014
Molecular pathways: targeting ETS gene fusions in cancerFelix Y Feng, J Chad Brenner, Maha Hussain, et al.
Translational Andrology and Urology|July 28, 2018
Genomic biomarkers in prostate cancerZachary Kornberg, Matthew R Cooperberg, Daniel E Spratt, et al.
Urology|June 26, 2019
Author ReplyLauren Boreta, Adam J Gadzinski, Thomas A Hope, et al.
Surgical Pathology Clinics|November 7, 2022
Molecular Genetics of Prostate Cancer and Role of Genomic TestingDilara Akhoundova, Felix Y Feng, Colin C Pritchard, et al.
Nature Reviews. Cancer|October 13, 2006
Integration of EGFR inhibitors with radiochemotherapyMukesh K Nyati, Meredith A Morgan, Felix Y Feng, et al.
Pageof 46